These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7859921)

  • 21. Two distinct pituitary cell lines from mouse intermediate lobe tumors: a cell that produces prolactin-regulating factor and a melanotroph [seecomments].
    Hnasko R; Khurana S; Shackleford N; Steinmetz R; Low MJ; Ben-Jonathan N
    Endocrinology; 1997 Dec; 138(12):5589-96. PubMed ID: 9389547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The uteroglobin promoter targets expression of the SV40 T antigen to a variety of secretory epithelial cells in transgenic mice.
    Sandmöller A; Halter R; Gómez-La-Hoz E; Gröne HJ; Suske G; Paul D; Beato M
    Oncogene; 1994 Oct; 9(10):2805-15. PubMed ID: 8084586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pit-1 gene expression in human pituitary adenomas using the reverse transcription polymerase chain reaction method.
    Yamada S; Takahashi M; Hara M; Hattori A; Sano T; Ozawa Y; Shishiba Y; Hirata K; Usui M
    Clin Endocrinol (Oxf); 1996 Sep; 45(3):263-72. PubMed ID: 8949563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A transgenic mouse line harboring a smooth muscle alpha-actin promoter polyomavirus middle T antigen transgene develops an epithelial hyperplasia in the rectum and distal stomach.
    Moghal N; Bonyadi S; Hassell JA; Alpert L; Chalifour LE
    Lab Invest; 1995 Mar; 72(3):291-9. PubMed ID: 7898048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determinants of thyrotrope-specific thyrotropin beta promoter activation. Cooperation of Pit-1 with another factor.
    Haugen BR; McDermott MT; Gordon DF; Rupp CL; Wood WM; Ridgway EC
    J Biol Chem; 1996 Jan; 271(1):385-9. PubMed ID: 8550592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of SV40 T antigen under control of rabbit uteroglobin promoter in transgenic mice.
    DeMayo FJ; Finegold MJ; Hansen TN; Stanley LA; Smith B; Bullock DW
    Am J Physiol; 1991 Aug; 261(2 Pt 1):L70-6. PubMed ID: 1872417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Morphology of adenohypophysial tumors in mice transgenic for vasopressin-SV40 hybrid oncogene.
    Stefaneanu L; Rindi G; Horvath E; Murphy D; Polak JM; Kovacs K
    Endocrinology; 1992 Apr; 130(4):1789-95. PubMed ID: 1312426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tissue-specific expression and activation of N-methylpurine-DNA glycosylase in thymic carcinomas of transgenic mice expressing the SV40 large T-antigen gene.
    Kim NK; Lee SH; Cha KY; Seo JS
    Mol Cells; 1998 Aug; 8(4):383-7. PubMed ID: 9749523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a novel member of the snail/Gfi-1 repressor family, mlt 1, which is methylated and silenced in liver tumors of SV40 T antigen transgenic mice.
    Tateno M; Fukunishi Y; Komatsu S; Okazaki Y; Kawai J; Shibata K; Itoh M; Muramatsu M; Held WA; Hayashizaki Y
    Cancer Res; 2001 Feb; 61(3):1144-53. PubMed ID: 11221845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transformation of astrocytes in transgenic mice expressing SV40 T antigen under the transcriptional control of the glial fibrillary acidic protein promoter.
    Danks RA; Orian JM; Gonzales MF; Tan SS; Alexander B; Mikoshiba K; Kaye AH
    Cancer Res; 1995 Oct; 55(19):4302-10. PubMed ID: 7671240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein factors in thyrotropic tumor nuclear extracts bind to a region of the mouse thyrotropin beta-subunit promoter essential for expression in thyrotropes.
    Wood WM; Ocran KW; Kao MY; Gordon DF; Alexander LM; Gutierrez-Hartmann A; Ridgway EC
    Mol Endocrinol; 1990 Dec; 4(12):1897-904. PubMed ID: 2082188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancer-mediated high level expression of mouse pituitary glycoprotein hormone alpha-subunit transgene in thyrotropes, gonadotropes, and developing pituitary gland.
    Kendall SK; Gordon DF; Birkmeier TS; Petrey D; Sarapura VD; O'Shea KS; Wood WM; Lloyd RV; Ridgway EC; Camper SA
    Mol Endocrinol; 1994 Oct; 8(10):1420-33. PubMed ID: 7531821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gonadectomy permits adrenocortical tumorigenesis in mice transgenic for the mouse inhibin alpha-subunit promoter/simian virus 40 T-antigen fusion gene: evidence for negative autoregulation of the inhibin alpha-subunit gene.
    Kananen K; Markkula M; Mikola M; Rainio EM; McNeilly A; Huhtaniemi I
    Mol Endocrinol; 1996 Dec; 10(12):1667-77. PubMed ID: 8961275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A morphological analysis endocrine tumour genesis in pancreas and anterior pituitary of AVP/SV40 transgenic mice.
    Rindi G; Bishop AE; Murphy D; Solcia E; Hogan B; Polak JM
    Virchows Arch A Pathol Anat Histopathol; 1988; 412(3):255-66. PubMed ID: 2829418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mice transgenic for a vasopressin-SV40 hybrid oncogene develop tumors of the endocrine pancreas and the anterior pituitary. A possible model for human multiple endocrine neoplasia type 1.
    Murphy D; Bishop A; Rindi G; Murphy MN; Stamp GW; Hanson J; Polak JM; Hogan B
    Am J Pathol; 1987 Dec; 129(3):552-66. PubMed ID: 2827490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SV40 T antigen directed by a powerful erythroid enhancer-promoter produced sarcomas and pancreatic tumors but not erythroid-specific tumors in transgenic mice.
    Teitz T; Yen TS; Chang JC; Kan YW
    DNA Cell Biol; 1994 Jul; 13(7):705-10. PubMed ID: 7772251
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pituitary and ovarian expression of the endogenous follicle-stimulating hormone (FSH) subunit genes and an FSH beta-subunit promoter-driven herpes simplex virus thymidine kinase gene in transgenic mice; specific partial ablation of FSH-producing cells by antiherpes treatment.
    Markkula M; Kananen K; Klemi P; Huhtaniemi I
    J Endocrinol; 1996 Aug; 150(2):265-73. PubMed ID: 8869593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thyroid adenocarcinomas secondary to tissue-specific expression of simian virus-40 large T-antigen in transgenic mice.
    Ledent C; Dumont J; Vassart G; Parmentier M
    Endocrinology; 1991 Sep; 129(3):1391-401. PubMed ID: 1714832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mouse transgenic for murine oviduct-specific glycoprotein promoter-driven simian virus 40 large T-antigen: tumor formation and its hormonal regulation.
    Miyoshi I; Takahashi K; Kon Y; Okamura T; Mototani Y; Araki Y; Kasai N
    Mol Reprod Dev; 2002 Oct; 63(2):168-76. PubMed ID: 12203826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pituitary adenomas in mice transgenic for growth hormone-releasing hormone.
    Asa SL; Kovacs K; Stefaneanu L; Horvath E; Billestrup N; Gonzalez-Manchon C; Vale W
    Endocrinology; 1992 Nov; 131(5):2083-9. PubMed ID: 1425411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.